Our Pricing

Switch to Wegovy at Cured Pharmacy: Compare Prices & Save Today

Published on: June 03, 2026

If you're ready to switch to Wegovy UK online pharmacy services, Cured Pharmacy offers transparent pricing from £79.00 with a free clinical consultation completed in under three minutes. Our UK-registered prescribers assess your suitability for semaglutide treatment, ensuring you receive genuine MHRA-licensed medication with complete clinical oversight.

Why Patients Switch to Wegovy from Other Weight Loss Treatments

Many UK patients switch to Wegovy after experiencing limited results with older weight loss medications or seeking a more convenient treatment schedule. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone regulating appetite and blood sugar levels [1]. Unlike daily injectable treatments, Wegovy requires just one subcutaneous injection per week, fitting more easily into busy lifestyles.

Clinical trial data demonstrates why switching may be beneficial. In the STEP 1 trial, participants achieved an average body weight reduction of 14.9% over 68 weeks when combined with lifestyle modifications [1]. This compares favourably to older treatments like orlistat, which typically produces 5-10% weight loss under similar conditions [2]. Patients often report improved tolerability and adherence with the once-weekly dosing schedule, though individual responses vary and treatment requires ongoing prescriber supervision.

Understanding Wegovy Pricing Across UK Pharmacies

Wegovy pricing varies significantly across UK online pharmacies, making price comparison essential before switching providers. At Cured Pharmacy, Wegovy starts from £79.00 per pen, with transparent pricing displayed before you begin your clinical consultation. We guarantee the lowest prices in the UK market, ensuring you're not overpaying for the same MHRA-licensed medication available elsewhere.

Pricing typically reflects the prescribed dose strength, which your UK prescriber determines based on your treatment stage and clinical response. Wegovy follows a dose escalation schedule, starting at 0.25mg weekly and increasing gradually to the maintenance dose of 2.4mg [3]. Some pharmacies bundle consultation fees or charge separately for prescriber assessments, but at Cured Pharmacy, your online consultation is completely free and takes under three minutes to complete.

When comparing costs, verify that prices include genuine UK-licensed Wegovy pens manufactured by Novo Nordisk. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) personally oversees dispensing to ensure every medication meets UK pharmaceutical standards. All orders include 100% discreet packaging and are dispatched from our GPhC-registered premises (9012511).

Hidden Costs to Watch When Switching Providers

Some online pharmacies advertise low headline prices but add consultation fees, delivery charges, or mandatory subscription commitments during checkout. At Cured Pharmacy, the price you see is the price you pay—no hidden fees, no automatic renewals, and no pressure to commit beyond your current prescription. This transparency helps you budget accurately and avoid unexpected charges when switching from another provider.

How to Switch to Wegovy: The Clinical Process

Switching to Wegovy requires a clinical assessment by a UK-registered prescriber, even if you're currently taking another weight loss medication. This ensures semaglutide is appropriate for your medical history and current health status. At Cured Pharmacy, the process begins with our free online consultation, which covers your weight loss goals, previous treatments, existing medical conditions, and any medications you currently take.

If you're switching from another GLP-1 treatment like Saxenda (liraglutide), your prescriber will provide guidance on transitioning safely. Generally, you'll complete your current medication cycle before starting Wegovy at the initial 0.25mg dose, following the standard escalation protocol [3]. If you're switching from non-injectable treatments like orlistat or Mysimba, the transition is typically more straightforward, though your prescriber will assess any contraindications.

Your UK prescriber may recommend switching to Wegovy if you've experienced gastrointestinal side effects with daily injectable treatments, need a more convenient dosing schedule, or haven't achieved sufficient weight loss with your current medication. Clinical decisions are made on an individual basis, considering factors like your BMI, weight loss history, and treatment goals. All prescription decisions remain at the prescriber's clinical discretion, subject to MHRA prescribing guidelines.

What Your Prescriber Needs to Know

During your consultation, be prepared to discuss your complete medical history, including thyroid conditions, pancreatitis history, diabetic retinopathy, and any family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. These factors influence prescribing decisions for semaglutide-based treatments [4]. Honest disclosure ensures your prescriber can make safe, informed decisions about your suitability for Wegovy.

Wegovy Dosing Schedule and What to Expect

Wegovy follows a structured dose escalation schedule designed to minimise gastrointestinal side effects while optimising weight loss outcomes. You'll begin at 0.25mg once weekly for four weeks, then increase to 0.5mg for four weeks, followed by 1mg, 1.7mg, and finally the maintenance dose of 2.4mg weekly [3]. Each dose increase allows your body to adjust gradually to higher semaglutide levels.

Most patients reach the maintenance dose after approximately 16-20 weeks, though your prescriber may adjust this timeline based on your tolerance and clinical response. In the STEP clinical programme, the majority of weight loss occurred during the dose escalation phase and early maintenance period, with continued gradual weight reduction over 68 weeks [1]. Patience during the initial months is essential, as results accumulate over time rather than appearing immediately.

Common side effects during dose escalation include nausea, diarrhoea, constipation, and reduced appetite [4]. These typically diminish as your body adjusts to each new dose level. Your prescriber may recommend slower escalation if you experience persistent gastrointestinal symptoms. Staying well-hydrated, eating smaller meals, and avoiding high-fat foods can help manage these effects during the adjustment period.

Wegovy vs Alternative Weight Loss Treatments

Understanding how Wegovy compares to alternative weight loss medications helps inform switching decisions. Semaglutide-based treatments like Wegovy work through GLP-1 receptor activation, slowing gastric emptying and reducing appetite through central nervous system pathways [1]. This mechanism differs from lipase inhibitors like orlistat, which prevent dietary fat absorption, and combination therapies like Mysimba, which act on reward and appetite centres in the brain.

Clinical trial comparisons show varying efficacy profiles. While Wegovy demonstrated average weight loss of 14.9% in STEP 1 [1], newer dual-agonist treatments have shown even higher reductions in some trials. However, Wegovy remains one of the most extensively studied weight loss medications available in the UK, with robust long-term safety data. Your prescriber will consider your treatment history, medical conditions, and personal preferences when recommending the most suitable option.

Cost considerations also influence treatment choice. At Cured Pharmacy, we stock the full range of licensed weight loss treatments, allowing your prescriber to recommend the most clinically appropriate option regardless of price point. Our transparent pricing model means you'll see exact costs before completing your consultation, enabling informed decisions about switching or continuing your current treatment.

Combining Wegovy with Lifestyle Modifications

Wegovy is licensed as an adjunct to reduced-calorie diet and increased physical activity, not as a standalone treatment [3]. Clinical trial results reflect participants who engaged in lifestyle counselling alongside medication. Your prescriber may provide guidance on sustainable dietary changes and activity levels that complement semaglutide therapy, optimising your weight loss outcomes while developing long-term healthy habits.

Starting Your Wegovy Treatment at Cured Pharmacy

Beginning your switch to Wegovy at Cured Pharmacy takes under three minutes through our streamlined online consultation. After accessing the assessment through our website, you'll answer questions about your medical history, current medications, weight loss goals, and previous treatments. Our UK-registered prescribers review every consultation individually, typically providing decisions within hours during business days.

If approved, your prescription is dispensed by our GPhC-registered pharmacy team under the supervision of superintendent pharmacist Tarun Kumar. We source all Wegovy pens directly from licensed UK wholesalers, guaranteeing genuine Novo Nordisk products with full cold-chain handling throughout storage and dispatch. Your medication arrives in 100% discreet packaging with no external markings indicating contents, protecting your privacy throughout delivery.

Ongoing prescriptions are managed through your Cured Pharmacy account, where you can request refills, update medical information, or contact our clinical team with questions. We don't operate mandatory subscription models—you control when and whether to continue treatment, with no automatic renewals or cancellation fees. This flexibility ensures you maintain control over your treatment journey while accessing the clinical support you need.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Sjöström, L., et al. (1998). Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. The Lancet, 352(9123), 167–172. https://doi.org/10.1016/S0140-6736(97)11509-4 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. Garvey, W. T., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.